A practical targeted molecular workflow resolves the World Health Organization 2021 integrated diagnosis of diffuse gliomas.
The 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System requires molecular alterations for the integrated diagnosis of diffuse gliomas but the necessity of comprehensive genomic profiling in routine practice remains uncertain. We retrospectively evaluated a practical molecular di...